Literature DB >> 23426125

End-stage sarcoid lung disease is distinct from usual interstitial pneumonia.

Lauren Xu1, Seth Kligerman, Allen Burke.   

Abstract

Sarcoid lung disease may result in progressive lung failure, necessitating transplant. There is a debate on whether the scarring is similar to or distinct from that seen in other fibrotic lung disease such as usual interstitial pneumonia (UIP). We prospectively evaluated histologic sections from 9 lung explants with end-stage sarcoid lung disease diagnosed clinically and by chest computed tomographic scans. The study included 7 women and 2 men. Four lungs showed active granulomatous disease, with nonfibrotic nodular granulomas in the interstitium; the other 5 were predominantly fibrotic, of which 3 had areas of honeycombing (cysts lined by respiratory epithelium with surrounding scar). Chest computed tomographs of 8 cases were all read as either probable or definite sarcoid. Patients in the fibrotic phase were significantly older (P=0.016). All cases showed dense acellular collagen, which was more extensive in the fibrotic phase. Granulomas were present in a lymphatic distribution (along bronchi, the lobular septa, and the pleura) and were predominantly small clusters of macrophages or giant cells embedded in scar in the fibrotic phase. Granulomas were not identified in 2 lungs in the fibrotic phase. In contrast to the honeycombing of UIP, the honeycombing was predominantly central, with prominent bronchiectasis. These end-stage sarcoid lungs were characterized by a fibrotic and active granulomatous pattern, both of which are very distinct from that seen in UIP.

Entities:  

Mesh:

Year:  2013        PMID: 23426125     DOI: 10.1097/PAS.0b013e3182785a2d

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  5 in total

Review 1.  Lung transplantation for pulmonary sarcoidosis.

Authors:  Keith C Meyer
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

Review 2.  Pathology of Sarcoidosis.

Authors:  Giulio Rossi; Alberto Cavazza; Thomas V Colby
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

Review 3.  From granuloma to fibrosis: sarcoidosis associated pulmonary fibrosis.

Authors:  Catherine A Bonham; Mary E Strek; Karen C Patterson
Journal:  Curr Opin Pulm Med       Date:  2016-09       Impact factor: 3.155

Review 4.  Combined Sarcoidosis and Idiopathic Pulmonary Fibrosis (CSIPF): A New Phenotype or a Fortuitous Overlap? Scoping Review and Case Series.

Authors:  Laura Bergantini; Gabriele Nardelli; Miriana d'Alessandro; Giusy Montuori; Caterina Piccioli; Elisabetta Rosi; Sara Gangi; Dalila Cavallaro; Paolo Cameli; Elena Bargagli
Journal:  J Clin Med       Date:  2022-04-06       Impact factor: 4.241

Review 5.  Developing better drugs for pulmonary sarcoidosis: determining indications for treatment and endpoints to assess therapy based on patient and clinician concerns.

Authors:  Marc A Judson
Journal:  F1000Res       Date:  2019-12-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.